Company Filing History:
Years Active: 2019-2023
Title: **Yuan-Ting Hsieh: Innovator in Neuropsychiatric Therapeutics**
Introduction
Yuan-Ting Hsieh is a notable inventor based in New Taipei, Taiwan. He has made significant contributions to the field of neuropsychiatric disorder treatments through his innovative research and patented inventions. With two patents to his name, Hsieh continues to advance therapeutic approaches in medicine.
Latest Patents
Hsieh's most recent invention, titled "D-amino acid oxidase inhibitors and therapeutic uses thereof," introduces compounds that may hold the key to treating neuropsychiatric disorders. The invention describes specific compounds of Formula (I), which can be pharmaceutically acceptable salts. The detailed composition consists of various moieties, with A, B, C, D, and E representing C, N, N—H, O, S, or being absent. The invention also outlines a method for inhibiting and treating disorders by administering a suitable composition to subjects in need. This innovative approach signifies a blend of chemistry and therapeutic applications aiming to benefit those affected by complex neuropsychiatric issues.
Career Highlights
Yuan-Ting Hsieh is associated with Syneurx International (Taiwan) Corporation, where he is part of a dedicated team focused on groundbreaking health solutions. His role has allowed him to explore and expand his expertise in pharmaceutical innovations, particularly those aimed at addressing neurochemical mechanisms underlying certain psychiatric conditions.
Collaborations
Hsieh collaborates with esteemed colleagues, including Guochuan Emil Tsai and Ching-Cheng Wang, who contribute their knowledge and skills to the research projects at Syneurx International (Taiwan) Corporation. These collaborations foster an environment of creativity and shared knowledge, which is vital for the development of effective therapeutic compounds.
Conclusion
Yuan-Ting Hsieh’s work in developing D-amino acid oxidase inhibitors represents a significant advance in neuropsychiatric treatment options. His innovative spirit and dedication to research, coupled with strong collaborations, position him as a crucial figure in the ongoing exploration of pharmaceutical innovations. As his work evolves, it holds promise for better healthcare solutions in treating complex mental health disorders.